A carregar...
US Budget Impact Model for Selinexor in Relapsed or Refractory Multiple Myeloma
Jan Bassali, 1 Ian Gopal Gould, 2 James A Kaye, 3 Deirdre Mladsi, 4 Jyotsna Mehta 5 1Global Medical and Scientific Affairs Department , Karyopharm Therapeutics, Newton, MA, 02459, USA; 2Research Health Economy, RTI Health Solutions, Research Triangle Park, NC 27709-2194, USA; 3Epidemiology, RTI H...
Na minha lista:
Main Authors: | , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2020-06-01
|
Colecção: | ClinicoEconomics and Outcomes Research |
Assuntos: | |
Acesso em linha: | https://www.dovepress.com/us-budget-impact-model-for-selinexor-in-relapsed-or-refractory-multipl-peer-reviewed-article-CEOR |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|